No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Specialty Business Services
RELX PLC is a global enterprise that furnishes professional and business clients with sophisticated information-based analytics and decision-making instruments across North America, Europe, and other international markets. Its operations are organized into four primary divisions: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment delivers advanced analytical and decision-support tools by integrating public and industry-specific content with cutting-edge technology and algorithms, empowering clients to evaluate and predict risks effectively. Through its Scientific, Technical & Medical segment, the company provides essential information and analytical insights, enabling institutions and professionals to foster scientific progress and enhance healthcare worldwide. The Legal segment offers comprehensive legal, regulatory, and commercial information alongside analytics, assisting customers in making well-informed decisions and boosting their operational efficiency. Furthermore, the Exhibitions segment manages a dynamic events portfolio, combining in-person interactions with data-driven and digital solutions to help attendees understand markets, source products, and finalize business transactions. Founded in 1903 and headquartered in London, United Kingdom, the organization operated as Reed Elsevier PLC before adopting the RELX PLC name in July 2015.
www.relx.comNo one on the platform currently holds REL.L.
No tracked institution reports a position in REL.L as of their last filing.
No one on the platform has traded REL.L yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-23 | $0.67 | $0.66 | -1.6% |
| 2026-02-12 | $0.63 | $0.60 | -5.1% |
| 2025-07-24 | $0.43 | $0.65 | +52.3% |
| 2025-02-13 | $0.61 | $0.60 | -1.5% |
| 2024-07-25 | $0.58 | $0.58 | +0.2% |
| 2024-02-15 | $0.58 | $0.58 | +1.4% |
| 2023-07-27 | $0.53 | $0.56 | +5.2% |
| 2023-02-16 | $0.54 | $0.55 | +2.2% |